MedTrace Logo

Effect of Single Dose Antenatal Betamethasone on Neonatal Respiratory Morbidity After Elective Cesarean

NCT04407975 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2020-06-01

No results posted yet for this study

Summary

Patients undergoing elective C-section will be randomized into two groups. The first group will receive one dose of Betamethasone at least 24 hours before scheduled C-section. The second group will receive placebo.

Conditions

  • Respiratory Morbidity

Interventions

OTHER

Betamethasone

A single injection will be administered to the patient at least 24 hours before undergoing C-section. This injection will be prepared in the hospital's pharmacy to contain betamethasone

OTHER

Placebo

A single injection will be administered to the patient. This injection will be prepared in the hospital's pharmacy to contain normal saline.

Sponsors & Collaborators

  • Makassed General Hospital

    lead OTHER

Principal Investigators

  • Manal Hubeish, MD · Makassed General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-29
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04407975 on ClinicalTrials.gov